Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients.

Kidney international - 1 May 1995

Pol S, Thiers V, Carnot F, Zins B, Romeo R, Berthelot P, Bréchot C

Abstract excerpt

A high frequency (25%) of anti-hepatitis C virus (HCV) antibodies is observed in French hemodialyzed patients; this is associated with detectable viremia in 85% and results in chronic hepatitis in more than 90%. We conducted a pilot study to examine the tolerance and efficacy of alpha-2b Interferon therapy upon HCV infection in hemodialyzed patients. Nineteen anti-HCV positive hemodialyzed patients were given a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to DNA, Viral
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Hepacivirus

Share to Molecular Sequence Data

Share to Recombinant Proteins

Share to RNA, Viral

Source

Identifiers

PMID: 7637270
DOI: 10.1038/ki.1995.198

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients.PMID 7637270Read ↗

Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C.Semantic proximity Read ↗

Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.Semantic proximity Read ↗

Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.Semantic proximity Read ↗

Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment.Semantic proximity Read ↗

The response to pegylated interferon alpha 2a in haemodialysis patients with hepatitis C virus infection.Semantic proximity Read ↗

Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4.Semantic proximity Read ↗

Prospective study of a high-intensity interferon-alpha regimen for chronic hepatitis C virus genotype 1b infection.Semantic proximity Read ↗

[HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].Semantic proximity Read ↗

Response to interferon alfa-2b therapy in mutitransfused children with beta-thalassemia and chronic hepatitis C.Semantic proximity Read ↗

Intravenous natural beta-interferon in white patients with chronic hepatitis C who are nonresponders to alpha-interferon.Semantic proximity Read ↗

Efficacy of Interferon A-2b monotherapy in Β-thalassemics with chronic hepatitis C.Semantic proximity Read ↗

Genes of major histocompatibility complex class II influence chronic C hepatitis treatment with interferon in hemodialysis patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.